I also investigated the Patent issue. Below is the companies response to my questions.
In addition Dr. Vamvakides is 76, holds ten patents, and as far as I can tell has never been involved in litigation of any kind, let alone patent cases.
Dear Mr. .....,
I am providing you with an addendum regarding your patent-related questions about Anavex Life Sciences Corp. (OTCQX: AVXL).
Regarding your question about Dr. Vamvakides’ contractual obligations, under the “2012 Addendum to the Contract for the Transfer of a Patent Invention and Scientific Collaboration” dated January 11, 2013, paragraph 3.4 states that in addition to rights already conveyed, Dr. Vamvakides conveys all rights of every nature with particular reference to the patent rights in the Project. The Project is the subject matter of the patent applications at issue.
Regarding your question about the time frame involved to obtain the required assignments, an assignment document can be obtained at any time. As noted earlier, Anavex anticipates resolving matters with Dr. Vamvakides.
Thank you for your interest in our client Anavex Life Sciences Corp. (OTCQX: AVXL).
In response to your question, Dr. Vamvakides is under contractual obligations to assign the intellectual property to Anavex. Anavex anticipates obtaining the required assignments in good time. On October 20, 2014 Anavex filed a provisional patent application USSN 62/065833. The quoted language relates to Anavex filed patent applications. As noted above, Dr. Vamvakides is under contractual obligations to assign the intellectual property to Anavex. Anavex anticipates obtaining any required documents in good time. Anavex believes that any issues with Dr. Vamvakides will be amicably resolved and will not materially impact Anavex’s programs.
Please do not hesitate to contact our office if we can be of further assistance.
Sincerely,
Adam Bello
